Smith H W, Huggins M B
J Gen Microbiol. 1983 Aug;129(8):2659-75. doi: 10.1099/00221287-129-8-2659.
A mixture of two phages, B44/1 and B44/2, protected calves against a potentially lethal oral infection with an O9:K30,99 enteropathogenic strain of Escherichia coli, called B44, when given before, but not after, the onset of diarrhoea; a mixture in which phage B44/3 was replaced by phage B44/3 was effective after the onset of diarrhoea. Calves that responded to phage treatment had much lower numbers of E. coli B44 in their alimentary tract than untreated calves. Usually, high numbers of phage B44/1 and rather lower numbers of phage B44/2 or B44/3 were present in the alimentary tract of these animals. At death, most calves that had not responded to treatment with phages B44/1 and B44/2 had high numbers of mutants of E. coli B44 resistant to phage B44/1 in their small intestine. Phage-treated calves that survived E. coli infection continued to excrete phage in their faeces, at least until the numbers of E. coli B44 also excreted were low. The phages survived longer than E. coli B44 in faecal samples taken from phage-treated calves and exposed to the atmosphere in an unheated animal house. Calves inoculated orally with faecal samples from phage-treated calves that contained sufficient E. coli B44 to cause a lethal infection remained healthy. A mixture of two phages, P433/1 and P433/2, and phage P433/1 alone cured diarrhoea in piglets caused by an O20:K101,987P strain of E. coli called P433. The numbers of the infecting bacteria and phages in the alimentary tract of the piglets resembled those in the calves. Another phage given to lambs 8 h after they were infected with an O8:K85,99 enteropathogenic strain of E. coli, called S13, reduced the numbers of these organisms in the alimentary tract and had an ameliorating effect on the course of the disease. No phage-resistant mutants of E. coli S13 were isolated from the lambs. The only mutants of E. coli B44 and P433 that emerged in the calves and piglets were K30- or K101- and resistant to phage B44/1 or P433/1 respectively; those tested were much less virulent than their parent strains.
两种噬菌体B44/1和B44/2的混合物,在腹泻发作前而非发作后给予时,可保护犊牛免受一种具有潜在致死性的O9:K30,99肠致病性大肠杆菌菌株(称为B44)的口服感染;一种用噬菌体B44/3替代的混合物在腹泻发作后有效。对噬菌体治疗有反应的犊牛其消化道中的大肠杆菌B44数量比未治疗的犊牛低得多。通常,这些动物的消化道中存在大量的噬菌体B44/1,而噬菌体B44/2或B44/3的数量相对较少。死亡时,大多数对噬菌体B44/1和B44/2治疗无反应的犊牛小肠中存在大量对噬菌体B44/1具有抗性的大肠杆菌B44突变体。在大肠杆菌感染中存活下来的经噬菌体治疗的犊牛至少在排出的大肠杆菌B44数量较低之前,其粪便中仍继续排出噬菌体。从经噬菌体治疗的犊牛采集并在未加热的动物舍中暴露于空气中的粪便样本中,噬菌体比大肠杆菌B44存活时间更长。口服接种含有足以引起致死性感染的大肠杆菌B44的经噬菌体治疗的犊牛粪便样本的犊牛保持健康。两种噬菌体P433/1和P433/2的混合物以及单独的噬菌体P433/1治愈了由一种称为P433的O20:K101,987P大肠杆菌菌株引起的仔猪腹泻。仔猪消化道中感染细菌和噬菌体的数量与犊牛相似。在羔羊感染一种称为S13的O8:K85,99肠致病性大肠杆菌菌株8小时后给予的另一种噬菌体,减少了这些生物体在消化道中的数量,并对疾病进程有改善作用。未从羔羊中分离出大肠杆菌S13的噬菌体抗性突变体。在犊牛和仔猪中出现的大肠杆菌B44和P433的唯一突变体分别是K30-或K101-,并分别对噬菌体B44/1或P433/1具有抗性;所测试的突变体的毒力远低于其亲本菌株。